Director, Oncology Translational Medicine
Lead the development and execution of biomarker and translational medicine strategies for late-stage oncology assets, integrating cutting-edge technologies to identify predictive biomarkers and optimise clinical decision-making. Collaborate across functions to align biomarker strategies with clinical development plans and support patient segmentation, dose selection, and regulatory strategies. Drive scientific innovation through real-world data, multi-omic analyses, and external partnerships to advance GSK’s oncology pipeline.